(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 76.53%.
Q32 Bio's earnings in 2026 is $29,821,000.On average, 5 Wall Street analysts forecast QTTB's earnings for 2026 to be -$38,438,914, with the lowest QTTB earnings forecast at -$58,321,817, and the highest QTTB earnings forecast at -$17,357,858.
In 2027, QTTB is forecast to generate -$59,876,929 in earnings, with the lowest earnings forecast at -$73,404,794 and the highest earnings forecast at -$37,327,075.